Hypotension and hypothalamic amine metabolism after long-term α-methyldopa infusions
- 1 July 1978
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 23 (4) , 313-322
- https://doi.org/10.1016/0024-3205(78)90015-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- On the role of ?-methyldopamine in the antihypertensive effect of ?-methyldopaNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1975
- Further evidence for a central hypotensive action of α-methyldopa in both the rat and catBritish Journal of Pharmacology, 1973
- Central nervous ?-adrenergic receptors and the mode of action of ?-methyldopaNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
- The significance of the relative potencies of noradrenaline and α-methylnoradrenaline for the mode of action of α-methyldopaJournal of Pharmacy and Pharmacology, 1971
- Interaction of DOPA Decarboxylase Inhibitors with the Effect of α‐Methyldopa on Blood Pressure and Tissue Monoamines in Rats1Acta Pharmacologica et Toxicologica, 1969
- Central hypotensive effect of α-methyldopaJournal of Pharmacy and Pharmacology, 1968
- A new principle for the fluorimetric determination of α-methylnoradrenalineJournal of Pharmacy and Pharmacology, 1968
- A Hypothesis for the Mode of Action of α-Methyldopa in Relieving HypertensionJournal of Pharmacy and Pharmacology, 1963
- In‐Vivo Decarboxylation of α‐Methyl DOPA and α‐Methyl MetatyrosineActa Physiologica Scandinavica, 1962
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960